Correlation between the expression of telomerase reverse transcriptase and proliferative activity in breast cancer cells using an immunocytochemical restaining method

Pathology International

Volumn 53, Issue 11, 2003, Pages 762-768

  Ikeda, Satoshi ^a,b   Shibata, Toshikatsu ^a   Eishi, Yoshinobu ^b   Takizawa, Touichiro ^b   Koike, Morio ^b  

^a TSUCHIURA KYODO GENERAL HOSPITAL   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Breast cancer; Immunohistochemistry; in situ hybridization; Ki 67; Telomerase reverse transcriptase

Indexed keywords

KI 67 ANTIGEN; MESSENGER RNA; RNA DIRECTED DNA POLYMERASE; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ARTICLE; BREAST ADENOCARCINOMA; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPH NODE METASTASIS; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CELL DIVISION; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KI-67 ANTIGEN; LYMPHATIC METASTASIS; MIDDLE AGED; TELOMERASE;

EID: 0344944825     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1827.2003.01551.x     Document Type: Article

References (28)

1. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787-91.
2. Meyerson M, Counter CM, Eaton EN et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 1997; 90: 785-95.
3. Tahara H, Yasui W, Tahara E et al. Immunohistochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 1999; 18: 1561-7.
4. Kumamoto H, Kinouchi Y, Ooya K. Telomerase activity and telomerase reverse transcriptase (TERT) expression in ameloblastomas. J Oral Pathol Med 2001; 30: 231-6.
5. Yasui W, Tahara E, Tahara H et al. Immunohistochemical detection of human telomerase reverse transcriptase in normal mucosa and precancerous lesions of the stomach. Jpn J Cancer Res 1999; 90: 589-95.
6. Falchetti ML, Pallini R, D'Ambrosio E et al. In situ detection of telomerase catalytic subunit mRNA in gliobrastoma multiforme. Int J Cancer 2000; 88: 895-901.
7. Billgren AM, Tani E, Leidberg A, Skoog L, Rutqvist LE. Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer. Breast Cancer Res Treat 2002; 71: 161-70.
8. Okayasu I, Mitomi H, Yamashita K et al. Telomerase activity significantly correlates with cell differentiation, proliferation and lymph node metastasis in colorectal carcinomas. J Cancer Res Clin Oncol 1998; 124: 444-9.
9. Albanell J, Lonardo F, Rusch V et al. High telomerase activity in primary lung cancers: Association with increased cell proliferation rates and advanced pathologic stage. J Natl Cancer Inst 1997; 89: 1609-15.
10. Clark GM, Osborne CK, Levitt D, Wu F, Kim NW. Telomerase activity and survival of patients with node-positive breast cancer. J Natl Cancer Inst 1997; 89: 1874-81.
11. Chou SJ, Chen CM, Harn HJ, Chen CJ, Liu YC. In situ detection of hTERT mRNA relates to Ki-67 labeling index on papillary thyroid carcinoma. J Surg Res 2001; 99: 75-83.
12. Mori N, Oka M, Hazama S et al. Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads. Br J Cancer 2000; 83: 1026-32.
13. Kumaki F, Kawai T, Hiroi S et al. Telomerase activity and expression of human telomerase RNA component and human telomerase reverse transcriptase in lung carcinomas. Hum Pathol 2001; 32: 188-95.
14. Kim NW, Piatyszek MA, Prowse KR et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-15.
15. Wei R, Younes M. Immunohistochemical detection of telomerase reverse transcriptase in colorectal adenocarcinoma and benign mucosa. Hum Pathol 2002; 33: 693-6.
16. Hiyama E, Gollahon L, Kataoka T et al. Telomerase activity in human breast tumors. J Natl Cancer Inst 1996; 88: 116-22.
17. Hiyama E, Saeki T, Hiyama K et al. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples. Cancer Cytopathol 2000; 90: 235-8.
18. Hara H, Yamashita K, Shinada J, Yoshimura H, Kameya T. Clinicopathologic significance of telomerase activity and hTERT expression in non-small cell lung cancer. Lung Cancer 2001; 34: 219-26.
19. Ebina Y, Yamada H, Fujino T et al. Telomerase activity correlates with histopathological factors in uterine endometrial carcinoma. Int J Cancer 1999; 84: 529-32.
20. Hoos A, Hepp HH, Kaul S et al. Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer 1998; 79: 8-12.
21. Shoji Y, Yoshinaga K, Inoue A, Iwasaki A, Sugihara K. Quantification of telomerase activity in sporadic colorectal carcinoma. Association with tumor growth and venous invasion. Cancer 2000; 88: 1304-309.
22. Nawaz S, Hashizumi TL, Markham NE, Shroyer AL, Shroyer K. Telomerase expression in human breast cancer with and without lymph node metastases. Am J Clin Pathol 1997; 107: 542-7.
23. Bieche I, Nogues C, Paradis V et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000; 6: 452-9.
24. Toomey D, Smyth G, Condron C et al. Immune function, telomerase, and angiogenesis in patients with primary, operable non-small cell lung carcinoma: Tumor size and lymph node status remain the most important prognostic features. Cancer 2001; 92: 2648-57.
25. Wintzer HO, Zipfel I, Schulte-Monting J, Hellerich U, von Kleist S. Ki-67 immunostaining in human breast tumors and its relationship to prognosis. Cancer 1991; 67: 421-8.
26. Lelle RJ, Heidenreich W, Stauch G, Gerdes J. The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma. Cancer 1987; 59: 83-8.
27. Kumaki F, Kawai T, Churg A et al. Expression of telomerase reverse transcriptase (TERT) in malignant mesotheliomas. Am J Surg Pathol 2002; 26: 365-70.
28. Bednarek AK, Sahin A, Brenner AJ, Johnston DA, Aldaz CM. Analysis of telomerase activity levels in breast cancer: Positive detection at the in situ breast carcinoma stage. Clin Cancer Res 1997; 3: 11-16.